Literature DB >> 6105048

Ocular penetration of beta-adrenergic blocking agents. An experimental study with atenolol, metoprolol, timolol and propranolol.

F E Ros, H C Innemee, P A van Zwieten.   

Abstract

A comparison was made between the ocular penetration of topically applied 14C-atenolol, 14C-timolol, 14C-propranolol and 3H-metoprolol by means of liquid scintillation counting. Only one eye was treated, the fellow eye served as a control. Blood plasma levels were measured as well. We could detect a relationship between the ocular penetration and the degree of lipophilicity of the drugs used, as was to be expected. Drugs with a higher degree of lipophilicity penetrated more readily into the eye, whereas they also achieved higher blood plasma levels. Relatively high concentrations of atenolol were found in the nicitating membrane, thus reflecting its poor ocular penetration. The concentrations detected in the untreated eye were low and probably cannot explain the marked reduction in intraocular pressure observed after unilateral instillation of active beta-adrenergic blocking drugs, as for instance timolol. Our findings suggest that the ocular penetration of beta-adrenergic blocking agents on topical application only plays a minor part in their ocular hypotensive effect.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6105048     DOI: 10.1007/bf00141456

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  15 in total

1.  [Clinical use and action mechanism of propranolol].

Authors:  O Tieri; A Polzella
Journal:  Ophthalmologica       Date:  1975       Impact factor: 3.250

Review 2.  Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-11       Impact factor: 9.546

3.  The pharmacology of atenolol.

Authors:  A M Barrett
Journal:  Postgrad Med J       Date:  1977       Impact factor: 2.401

4.  Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit.

Authors:  P Vareilles; D Silverstone; B Plazonnet; J C Le Douarec; M L Sears; C A Stone
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-11       Impact factor: 4.799

5.  Penetration of atenolol in the rabbit eye.

Authors:  F E Ros; H C Innemee; P A van Zwieten
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-11-30

6.  Lipophilicity and brain disposition of clonidine and structurally related imidazolidines.

Authors:  P B Timmermans; A Brands; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

7.  Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.

Authors:  H C Brown; S G Carruthers; G D Johnston; J G Kelly; J McAinsh; D G McDevitt; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875

8.  Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

9.  Timolol, dose response and duration of action.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

10.  Atenolol eye drops in glaucoma: a double-masked, controlled study.

Authors:  C I Phillips; S M Gore; M J Macdonald; P M Cullen
Journal:  Br J Ophthalmol       Date:  1977-05       Impact factor: 4.638

View more
  8 in total

1.  Penetration of timolol eye drops into human aqueous humour: the first hour.

Authors:  C I Phillips; R S Bartholomew; A M Levy; J Grove; R Vogel
Journal:  Br J Ophthalmol       Date:  1985-03       Impact factor: 4.638

2.  The role of beta 2-adrenoceptors in the IOP-lowering effect of adrenaline.

Authors:  H C Innemee; P A van Zwieten
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1982       Impact factor: 3.117

3.  Influence of the strength, drop size and viscosity of metipranolol eye drops on the concentration of the substance in human aqueous humour.

Authors:  C Kessler; H Bleckmann; G Kleintges
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

4.  Influence of the concentration of metipranolol eye drops on the drug concentration in human aqueous humour.

Authors:  C Kessler; H Bleckmann; G Kleintges
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

5.  Microdialysis evaluation of the ocular pharmacokinetics of propranolol in the conscious rabbit.

Authors:  K D Rittenhouse; R L Peiffer; G M Pollack
Journal:  Pharm Res       Date:  1999-05       Impact factor: 4.200

6.  Penetration of timolol eye drops into human aqueous humour.

Authors:  C I Phillips; R S Bartholomew; G Kazi; C J Schmitt; R Vogel
Journal:  Br J Ophthalmol       Date:  1981-09       Impact factor: 4.638

7.  How can the bioavailability of timolol be enhanced? A pharmacokinetic pilot study of novel hydrogels.

Authors:  N von der Ohe; M Stark; H Mayer; H Brewitt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-07       Impact factor: 3.117

8.  Penetration of five beta-adrenergic antagonists into the rabbit eye after ocular instillation.

Authors:  C Schmitt; V J Lotti; J C Le Douarec
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.